GSLLX
Price
$23.27
Change
+$0.09 (+0.39%)
Updated
Jul 25 closing price
Net Assets
463.48M
VFFSX
Price
$312.76
Change
+$1.26 (+0.40%)
Updated
Jul 25 closing price
Net Assets
1.49T
Interact to see
Advertisement

GSLLX vs VFFSX

Header iconGSLLX vs VFFSX Comparison
Open Charts GSLLX vs VFFSXBanner chart's image
Goldman Sachs Enhanced U.S. Equity I
Price$23.27
Change+$0.09 (+0.39%)
VolumeN/A
Net Assets463.48M
Vanguard 500 Index Institutional Select
Price$312.76
Change+$1.26 (+0.40%)
VolumeN/A
Net Assets1.49T
GSLLX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSLLX vs. VFFSX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSLLX is a Buy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.49T vs. GSLLX (463M). VFFSX pays higher dividends than GSLLX: VFFSX (1.23) vs GSLLX (0.49). GSLLX was incepted earlier than VFFSX: GSLLX (17 years) vs VFFSX (9 years). GSLLX (1.00) is less costly to investors than VFFSX (0.01). GSLLX is a more actively managed with annual turnover of: 79.00 vs. VFFSX (2.00). GSLLX has a lower initial minimum investment than VFFSX: GSLLX (0) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 17.94 vs. GSLLX (14.36). VFFSX return over 5 years is better than : 98.17 vs. GSLLX (76.36).
GSLLXVFFSXGSLLX / VFFSX
Total Expense Ratio0.680.016,800%
Annual Report Gross Expense Ratio1.000.0110,000%
Fund Existence17 years9 years-
Gain YTD6.0878.27874%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets463M1.49T0%
Annual Yield % from dividends0.491.2340%
Returns for 1 year14.3617.9480%
Returns for 3 years58.6962.5094%
Returns for 5 years76.3698.1778%
Returns for 10 years84.57N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACTU7.260.27
+3.86%
Actuate Therapeutics Inc
NCL0.19N/A
+2.06%
Northann Corp
WAT302.954.48
+1.50%
Waters Corp
ACVA14.58-0.05
-0.34%
ACV Auctions Inc
STOK13.10-0.41
-3.03%
Stoke Therapeutics